Add pharmacy selection errors, a major pharmaceutical manufacturer, labels, and the U.S. Food and Drug Administration, and it may well sound like an alarming recipe. But that’s not the case this time.
In fact, in a June 10 announcement, the FDA announced the “approval of Merck’s redesigned drug container labels that include a new standardized format to improve readability and provide better information on product and strength differentiation.”
